The Latest Breaking News from Barchart

Today, a large volume of in-the-money (ITM) call options in Corning Inc. stock traded, highlighting its underlying value. The optic fiber company has attracted value investors with its strong free cash flow results.

Summary National Fuel Gas Company (NFG) shows strong technical buy signals, gaining 21.97% since Trend Seeker's buy signal on 1/13, with consistent price appreciation. NFG operates in four segments: Exploration and Production, Pipeline and Storage, Gathering, and Utility, providing diversified energy services in Pennsylvania and New York. Barchart's technical indicators...

Lyft generated $766 million in free cash flow (FCF) last year, or over 13% of its revenue. However, LYFT stock has a 15% FCF yield now - too high. Based on a conservative 10% FCF yield, LYFT could be worth at least 31.5% more.

BTG stock attracting attention from the smart money is already a noteworthy development. Flashing the J-Hook adds the cherry on top.

Despite the bullish sentiment in the gold market, traders should remain cautious. Gold has been on a relentless upward trajectory since September 2022, leading some analysts to question whether the metal is already over-priced at these levels. As early investors look to cash in on profits, the risk of a…

These three Dividend Aristocrats care about profitability, predictable dividend growth, and sustainable payout ratios for their income investors.

Microsoft may have bottomed, which could be a good entry point for value investors. Selling short out-of-the-money puts in nearby expiry periods sets a lower buy-in target and lets investors get paid while waiting.

Amid a strengthening case for the fear trade, the precious metals complex potentially offers one of the rare avenues for robust capital gains.

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....